Sagent famotidine injection recalled for particulate matter
Sagent Pharmaceuticals is recalling 1,720 vials of famotidine injection, 200 mg per 50 mL (4 mg per mL), because of the presence of particulate matter. The recall covers lots 260327 and 260803, distributed across the US. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Talk to your pharmacist or prescriber before stopping it.
- Check the NDC 25021-756-50 and lot number on the vial. The affected lots are 260327 (best by 7-27-27 and 9-27-27) and 260803 (best by 2-03-28).
- The notice doesn't say how to get a refund or replacement; contact Sagent Pharmaceuticals or where you received the vial.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Famotidine Injection, 200 mg per 50 mL (4 mg per mL), 1 x 50 mL Multi-Dose Vial, For Intravenous Use, Rx only, Sterile, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60173. NDC: 25021-756-50
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 1,720 vials
- Illnesses reported
- None reported
- Manufactured in
- 1515 E Woodfield Rd Ste 1100, Schaumburg, Illinois, United States
- Classification
- Class II
- Recall number
- D-0185-2027
In the FDA's words
- Description
- Famotidine Injection, 200 mg per 50 mL (4 mg per mL), 1 x 50 mL Multi-Dose Vial, For Intravenous Use, Rx only, Sterile, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60173. NDC: 25021-756-50 Presence of Particulate Matter Various lots (see firm press release: https://www.prnewswire.com/news-releases/wedgewood-pharmacy-issues-recall-of-certain-compounded-veterinary-medications-within-expiry-due-to-potential-potency-issues-302915780.html); Exp Date Range: 10/17/2026 - 01/16/2027 Distribution: US Nationwide Affected quantity: 1,720 vials
- Hazard
- Presence of Particulate Matter